Literature DB >> 7689895

Granulocyte colony-stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear cells.

Y Yamamoto1, T W Klein, H Friedman, S Kimura, H Yamaguchi.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) stimulates a subset of granulocyte colony forming cells and when administered to neutropenic individuals results in recovery of blood neutrophil numbers to normal levels. Therefore, G-CSF may be a useful therapeutic agent for infections in immunocompromised hosts. However, to date there has been only limited information that G-CSF activates the antimicrobial activity of neutrophils. In the present study, we found that recombinant G-CSF promotes the anti-Candida albicans activity of normal human blood polymorphonuclear (PMN) cells in vitro using both a 3H-glucose uptake procedure and a Candida colony counting assay. As little as 0.1 ng/ml G-CSF induced significant anti-Candida activity in the PMN cultures. G-CSF treatment also enhanced superoxide anion production by the PMNs in response to f-MLP as determined by the superoxide dismutase inhibitable cytochrome C reduction method. Such results show that G-CSF can promote the antimicrobial activity of peripheral blood PMNs against C. albicans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689895     DOI: 10.1111/j.1574-695X.1993.tb00376.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  7 in total

Review 1.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

Review 2.  Trends in immunotherapy of fungal infections.

Authors:  B J Kullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

3.  Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.

Authors:  Alieke G Vonk; Mihai G Netea; Johan H van Krieken; Paul E Verweij; Jos W M van der Meer; Bart Jan Kullberg
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 4.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

5.  A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans.

Authors:  Jeffrey Tomalka; Sandhya Ganesan; Elaheh Azodi; Krupen Patel; Parth Majmudar; Brian A Hall; Katherine A Fitzgerald; Amy G Hise
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

6.  Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor.

Authors:  Jemima Ho; Xuexin Yang; Spyridoula-Angeliki Nikou; Nessim Kichik; Andrew Donkin; Nicole O Ponde; Jonathan P Richardson; Remi L Gratacap; Linda S Archambault; Christian P Zwirner; Celia Murciano; Rhonda Henley-Smith; Selvam Thavaraj; Christopher J Tynan; Sarah L Gaffen; Bernhard Hube; Robert T Wheeler; David L Moyes; Julian R Naglik
Journal:  Nat Commun       Date:  2019-05-24       Impact factor: 14.919

Review 7.  Candidalysin: discovery and function in Candida albicans infections.

Authors:  Julian R Naglik; Sarah L Gaffen; Bernhard Hube
Journal:  Curr Opin Microbiol       Date:  2019-07-06       Impact factor: 7.934

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.